Pharmaplatin

Administer as IV push or bolus over 15 min up to a continuous intravenous infusion over 24 hour, reconstitute powder to yield a final concentration of 10 mg/ml. May also be administered intraperitoneally. When administered as swquential infusions, tisane derivatives (docetaxel, paclitacel) should be administered before platinum derivatives to limit myelosuppression and to enhance efficacy. Do not use needles or IV administration sets containing aluminium parts that may come in contact with carboplation (aluminium can react causing precipitate formation and losss of potency)